Skip to main content

Table 3 Phase 1 evaluation of inter-rater reliability and test-retest stability

From: Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC)

 

Recruiter info–quantity

Recruiter info– clarity

Patient talk–quantity

Patient talk–understanding

Phase 1: inter-rater reliability

  N of comparisons

126

126

126

126

  N of comparisons showing ≤1-point discrepancy (% of total comparisons)

111 (88.10)

92 (73.02)

113 (89.68)

89 (70.63)

  N of comparisons showing 2-point discrepancy (% of total comparisons)

13 (10.32)

5 (3.97)

10 (7.94)

7 (5.56)

  N of comparisons showing ≥3-point discrepancy (% of total comparisons)

2 (1.59)

29 (23.02)a

3 (2.38)

30 (23.81)a

  aIncludes those comparisons where N/A (coded 9) was marked for one application of the measure and not the other

Phase 1: test-retest stability

  N of comparisons

126

126

126

126

  N of comparisons showing ≤1-point discrepancy (% of total comparisons)

124 (98.41)

116 (92.06)

124 (98.41)

114 (90.48)

  N of comparisons showing 2-point discrepancy (% of total comparisons)

2 (1.59)

1 (0.79)

2 (1.59)

1 (0.79)

  N of comparisons showing ≥3-point discrepancy (% of total comparisons)a

0 (0.00)

9 (7.14)a

0 (0.00)

11 (8.73)a

  1. aIncludes those comparisons where N/A (coded 9) was marked by one rater and not the other